The onset of cancer takes place when cells in the body begin to malfunction and divide rapidly, causing abnormal growth of excess tissues (called tumors). At Mississippi Gynecologic Cancer Group, it’s our calling and our mission to treat the widest variety of gynecologic cancers as quickly and effectively as possible.
Ovarian Cancer
Ovarian cancer originates in the ovaries. The ovaries, located on each side of the uterus, are the pair of
reproductive organs that produce eggs and are the main source of the primary female hormones,
estrogen and progesterone. In 2008, it was estimated that 21,650 new cases of ovarian cancer would be
diagnosed in the U.S. and 15,520 deaths would result. Ovarian cancer is the most lethal of the
gynecologic malignancies.
Cervical Cancer
Cervical cancer originates in the lower part of the uterus, the cervix, which is visible during a vaginal
examination. In 2008, it was estimated that 11,070 women would be diagnosed and 3,870 women would die from cervical cancer in the U.S.
Endometrial Cancer
Endometrial cancer originates in the endometrium (the inner lining of the uterus that sheds with monthly
menstrual periods). The most common cancer of the female reproductive organs, it was estimated that
40,100 new cases would be diagnosed in 2008 and 7,470 deaths would occur in the U.S.
Endometrial cancers which arise from the lining of the uterus (the hollow, pear-shaped organ where a
baby grows during pregnancy) are known as Uterine Sarcomas, and represent the majority of uterine
cancers. Uterine sarcomas are uncommon. It was estimated that 40,100 new cases of uterine cancer would be diagnosed in the U.S. during 2008, but less than five percent will be uterine sarcomas.
Vulvar Cancer
Vulvar cancer, a rare cancer that represents only four percent of all female reproductive cancers,
originates in the outer part of the female reproductive system (the clitoris, vaginal lips and opening of the
vagina). In 2008, it was estimated that 3,460 new cases would be diagnosed and 870 would die from
vulvar cancer in the U.S.
Vaginal Cancer
Cancer of the vagina, a rare cancer accounting for about two to three percent of female reproductive
cancers, is a disease in which malignant cells are found in the tissues of the vagina. It was estimated that
in the year 2008, about 2,210 new cases of vaginal cancer would be diagnosed in the U.S. and 760
women would die of this cancer.
Fallopian Tube Cancer
This is the abnormal growth of malignant cells in one or both of a woman's fallopian tubes, the twin ducts that transport a woman's eggs from the ovaries to the uterus.
Genetic Testing
A test for hereditary breast and ovarian cancer
BRACAnalysis® assesses a woman's risk of developing breast or ovarian cancer based on detection of mutations in the BRCA1 and BRCA2 genes. This test has become the standard of care in identification of individuals with hereditary breast and ovarian cancer and is reimbursed by insurance. » More Info.

You can count on the professionals at Mississippi Gynecologic Cancer Group to give their very best to the diagnosis and treatment of the conditions listed above and many others less common.
If you or a loved one is dealing with one of the conditions above, there are resources available for your education and piece of mind. Explore the appropriate links on our site to learn more.
